AAA
Attovia Therapeutics, Inc.
No trades
No trades
Compare with Attovia Therapeutics, Inc.
−60.90 M USD
1.35 M USD
27.39 M
Last report date
Sep 2, 2026
Report period
Q2 2026
EPS
−4.88 USD
Revenue
450.00 K USD
Company info
Sector
Industry
CEO
Tao Fu
Website
Headquarters
San Carlos
Founded
2022
IPO date
Aug 5, 2026
IPO offer price
17.00 USD
ISIN
US04987L1026
CUSIP
04987L102
FIGI
BBG01H3TV5J8
Identifiers
ISIN US04987L1026
Attovia Therapeutics, Inc. is a biopharmaceutical company developing precision multispecific biologics to address immune-mediated and inflammatory diseases, including dermatology conditions such as atopic dermatitis and chronic pruritus, and gastroenterology disorders like inflammatory bowel disease. The company is based in San Carlos, CA. The company utilizes its proprietary Attobody™ platform to design novel multispecific molecules that inhibit multiple disease-driving pathways. Key pipeline candidates include ATTO-1310 (anti-IL31) and ATTO-3712 (anti-IL31 x IL13), both in phase 1 clinical trials for chronic pruritus and inflammatory skin disease, and ATTO-1091, a trispecific molecule in IND-enabling stages for inflammatory bowel disease. The company was founded in 2022 by Petter Veiby, Tao Fu, Zaneta Odrowaz. Tao Fu has been the CEO of the company since 2022.
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Frequently asked questions
The current price of ATTO is 23.66 USD — it has decreased by −7.40% in the past 24 hours. Watch Attovia Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Attovia Therapeutics, Inc. stocks are traded under the ticker ATTO.
ATTO stock has risen by 9.49% compared to the previous week, the month change is a 17.65% rise, over the last year Attovia Therapeutics, Inc. has showed a 12.67% increase.
We've gathered analysts' opinions on Attovia Therapeutics, Inc. future price: according to them, ATTO price has a max estimate of 52.00 USD and a min estimate of 30.00 USD. Watch ATTO chart and read a more detailed Attovia Therapeutics, Inc. stock forecast: see what analysts think of Attovia Therapeutics, Inc. and suggest that you do with its stocks.
ATTO reached its all-time high on Sep 8, 2026 with the price of 28.00 USD, and its all-time low was 16.15 USD and was reached on Aug 12, 2026. View more price dynamics on ATTO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ATTO stock is 18.59% volatile and has beta coefficient of −0.96. Track Attovia Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Attovia Therapeutics, Inc. there?
Today Attovia Therapeutics, Inc. has the market capitalization of 1.17 B, it has increased by 13.66% over the last week.
Yes, you can track Attovia Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Attovia Therapeutics, Inc. is going to release the next earnings report on Dec 2, 2026. Keep track of upcoming events with our Earnings Calendar.
ATTO earnings for the last quarter are −4.88 USD per share, whereas the estimation was −0.65 USD resulting in a −655.81% surprise. The estimated earnings for the next quarter are −0.56 USD per share. See more details about Attovia Therapeutics, Inc. earnings.
Attovia Therapeutics, Inc. revenue for the last quarter amounts to 450.00 K USD, despite the estimated figure of 316.67 K USD. In the next quarter, revenue is expected to reach 0.00 USD.
ATTO net income for the last quarter is −20.69 M USD, while the quarter before that showed −18.66 M USD of net income which accounts for 0.00% change. Track more Attovia Therapeutics, Inc. financial stats to get the full picture.
No, ATTO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ATTO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Attovia Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.